61. The Association between ACE Inhibitor or Angiotensin Receptor Blocker Use during Postischemic Acute Transplant Failure and Renal Allograft Survival. Transplantation 2006, 82:1441-1448. (IF 5.3)

Heinze G, Collins S, Benedict MA, Nguyen LL, Kramar R, Winkelmayer WC, Haas M, Kainz A, Oberbauer R.

59. Complete renal tubular acidosis late after kidney transplantation. Nephrol Dial Transplant 2006, 21:2615-2620. (IF 4.8)

Schwarz C, Benesch T, Kodras K, Oberbauer R, Haas M.

58. Effects of Bisphosphonates on Bone Loss in the First Year after Renal Transplantation: A Metaanalysis of Randomized Controlled Trials. Nephrol Dial Transplant 2006, 21:2275-2281. (IF 4.8)

Mitterbauer C, Schwarz C, Haas M, Oberbauer R.

57. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity. Wien Klin Wochenschr. 2006, 118(1-2):49-53. (IF 1.9)

Worel N, Schulenburg A, Mitterbauer M, Keil F, Rabitsch W, Kalhs P, Gisslinger H, Raderer M, Geissler K, Hocker P, Zielinski CC, Oberbauer R, Greinix HT.

56. Molecular signature of mice T lymphocytes following tolerance induction by allogeneic BMT and CD40-CD40L costimulation blockade. Transpl Int. 2006, 19:146-157. (IF 2.7)

Perco P, Blaha P, Kainz A, Mayer B, Hauser P, Wekerle T, Oberbauer R.

55. Sirolimus therapy after early cyclosporine withdrawal reduces the risk of cancer in adult renal transplantation. J Am Soc Nephrol 2006, 17:581-589. (IF 10.3)

Campistol JM, Eris J, Oberbauer R, Friend P, Hutchison B, Morales JM, Claesson K, Stallone G, Russ G, Rostaing L, Kreis H, Burke JT, Brault Y, Scarola JA and Neylan JF for the Rapamune Maintenance Regimen (RMR) Study Group.

54. Angiotensin-converting enzyme inhibitor or AT1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006, 17:889-899. (IF 10.3)

Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer W, Curhan G, Oberbauer R.

SCIENTIFIC COLLABORATIONS